These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 18804387)
41. Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus. Pan Z; Zhang X; Geng S; Cheng N; Sun L; Liu B; Huang J; Jiao X Vaccine; 2009 Feb; 27(7):1018-23. PubMed ID: 19103246 [TBL] [Abstract][Full Text] [Related]
42. Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. D'Aoust MA; Lavoie PO; Couture MM; Trépanier S; Guay JM; Dargis M; Mongrand S; Landry N; Ward BJ; Vézina LP Plant Biotechnol J; 2008 Dec; 6(9):930-40. PubMed ID: 19076615 [TBL] [Abstract][Full Text] [Related]
43. Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection. Ansaldi F; Canepa P; Parodi V; Bacilieri S; Orsi A; Compagnino F; Icardi G; Durando P Vaccine; 2009 May; 27(25-26):3345-8. PubMed ID: 19200846 [TBL] [Abstract][Full Text] [Related]
44. Anaphylaxis from the influenza virus vaccine. Coop CA; Balanon SK; White KM; Whisman BA; Rathkopf MM Int Arch Allergy Immunol; 2008; 146(1):85-8. PubMed ID: 18087166 [TBL] [Abstract][Full Text] [Related]
45. Baculovirus as an expression and/or delivery vehicle for vaccine antigens. Hu YC; Yao K; Wu TY Expert Rev Vaccines; 2008 Apr; 7(3):363-71. PubMed ID: 18393606 [TBL] [Abstract][Full Text] [Related]
46. Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses. Kreijtz JH; Suezer Y; de Mutsert G; van den Brand JM; van Amerongen G; Schnierle BS; Kuiken T; Fouchier RA; Löwer J; Osterhaus AD; Sutter G; Rimmelzwaan GF Vaccine; 2009 Oct; 27(45):6296-9. PubMed ID: 19840663 [TBL] [Abstract][Full Text] [Related]
47. Antibody response to influenza vaccine in coronary artery disease: a substudy of the FLUCAD study. Brydak LB; Romanowska M; Nowak I; Ciszewski A; Bilińska ZT Med Sci Monit; 2009 Jul; 15(7):PH85-91. PubMed ID: 19564837 [TBL] [Abstract][Full Text] [Related]
49. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice. Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H J Gene Med; 2009 Jan; 11(1):57-65. PubMed ID: 19006097 [TBL] [Abstract][Full Text] [Related]
50. The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors. Felberbaum RS Biotechnol J; 2015 May; 10(5):702-14. PubMed ID: 25800821 [TBL] [Abstract][Full Text] [Related]
51. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity. Reisinger KS; Block SL; Izu A; Groth N; Holmes SJ J Infect Dis; 2009 Sep; 200(6):849-57. PubMed ID: 19673652 [TBL] [Abstract][Full Text] [Related]
52. [Evaluation of a radial immunodiffusion method for the quantitative determination of influenza virus hemagglutinin]. Chubarova NI Tr Inst Im Pastera; 1982; 59():94-6. PubMed ID: 6821266 [No Abstract] [Full Text] [Related]
53. Expression and production of human interleukin-7 in insect cells using baculovirus expression vector system (BEVS). Mirzaei M; Jardin B; Elias CB; Prakash S Appl Biochem Biotechnol; 2008 Oct; 151(1):93-103. PubMed ID: 18546077 [TBL] [Abstract][Full Text] [Related]
55. [Methods of isolating the hemagglutinin of the influenza virus (a review)]. Negrianu GM Tr Inst Im Pastera; 1982; 59():98-105. PubMed ID: 6764989 [No Abstract] [Full Text] [Related]
57. The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing. Trombetta CM; Marchi S; Montomoli E Expert Rev Vaccines; 2022 Sep; 21(9):1233-1242. PubMed ID: 35678205 [TBL] [Abstract][Full Text] [Related]
58. Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture. Szymczakiewicz-Multanowska A; Groth N; Bugarini R; Lattanzi M; Casula D; Hilbert A; Tsai T; Podda A J Infect Dis; 2009 Sep; 200(6):841-8. PubMed ID: 19673651 [TBL] [Abstract][Full Text] [Related]
59. Influenza control in the 21st century: Optimizing protection of older adults. Monto AS; Ansaldi F; Aspinall R; McElhaney JE; Montaño LF; Nichol KL; Puig-Barberà J; Schmitt J; Stephenson I Vaccine; 2009 Aug; 27(37):5043-53. PubMed ID: 19559118 [TBL] [Abstract][Full Text] [Related]
60. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza. Shoji Y; Bi H; Musiychuk K; Rhee A; Horsey A; Roy G; Green B; Shamloul M; Farrance CE; Taggart B; Mytle N; Ugulava N; Rabindran S; Mett V; Chichester JA; Yusibov V Vaccine; 2009 Feb; 27(7):1087-92. PubMed ID: 19100806 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]